$44.54 -0.25 (%) GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs - NYSE

May. 29, 2015 | 10:00 AM

Partner Headlines

  1. Big Pharma Companies Are Betting On Regenerative Medicine - Should You?

    GuruFocus | May. 26, 2015 | 13:35PM EST
  2. Analyst Says GlaxoSmithKline Acquisition Will Benefit Pfizer

    GuruFocus | May. 22, 2015 | 18:21PM EST
  3. 9 International Dividend Dogs With Upside Potential

    GuruFocus | May. 22, 2015 | 16:48PM EST
  4. Endo International Acquires Par Pharmaceuticals For $8 Billion

    GuruFocus | May. 21, 2015 | 10:48AM EST
  5. Tweedy Browne's Stocks With High Growing Yield

    GuruFocus | May. 11, 2015 | 18:39PM EST
  6. Kahn Brothers Ups Investment in 4 Stocks

    GuruFocus | May. 8, 2015 | 14:39PM EST
  7. Glaxo more bullish than Q1

    IBD | May. 6, 2015 | 18:59PM EST
  8. IPO Stock Watch: Adaptimmune Upsizes But Stock Slips

    IBD | May. 6, 2015 | 17:20PM EST
  9. Glaxo Q1 Earnings Miss, But 5-Year Guidance Strong

    IBD | May. 6, 2015 | 12:49PM EST
  10. Isis Pharma Up As Bayer Licenses Thrombosis Drug

    IBD | May. 4, 2015 | 13:03PM EST
  11. GlaxoSmithKline

    IBD | Apr. 27, 2015 | 18:45PM EST
  12. Novartis EPS beats the Street

    IBD | Apr. 23, 2015 | 18:33PM EST
  13. Taking a Closer Look at GlaxoSmithKline

    GuruFocus | Apr. 22, 2015 | 12:37PM EST
  14. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices

    Benzinga | Feb. 20, 2015 | 13:10PM EST
  15. New Potential HIV Vaccine Drug 'Absolutely 100% Effective' In Monkeys

    Benzinga | Feb. 20, 2015 | 07:22AM EST
  16. Dodge & Cox 2014 Equity Year in Review

    GuruFocus | Feb. 19, 2015 | 18:29PM EST
  17. Why Muscular Dystrophy Is Biotech's Favorite Orphan

    IBD | Feb. 19, 2015 | 16:59PM EST
  18. Making Money With Charles Payne: 02/13/15

    FoxBusiness | Feb. 13, 2015 | 18:00PM EST
  19. Simons-Founded Renaissance Technologies Buys Apple, Closes Facebook, Trims McDonald's In Q4

    Benzinga | Feb. 13, 2015 | 14:19PM EST
  20. Stocks Edge Higher Friday; Glaxo, Taiwan Semi Muscle Up

    IBD | Feb. 13, 2015 | 10:41AM EST
  21. Bestinfond's Top 5 New Buys During Q4

    GuruFocus | Feb. 3, 2015 | 16:15PM EST
  22. Mylan Makes Deals In Women's Health, Lung Disease

    IBD | Feb. 2, 2015 | 12:48PM EST
  23. Can GlaxoSmithKline Continue Striving in the Face of World Challenges?

    GuruFocus | Jan. 30, 2015 | 11:17AM EST
  24. GlaxoSmithKline Expands Its Portfolio Of Medicines In The US For Patients With Asthma And COPD

    Benzinga | Jan. 26, 2015 | 09:21AM EST
  25. Benzinga's Weekend M&A Chatter

    Benzinga | Jan. 25, 2015 | 18:50PM EST
  26. Gilead Sciences Still has More Upside

    GuruFocus | Jan. 22, 2015 | 15:28PM EST
  27. Johnson & Johnson Riding High On Ebola Vaccines

    GuruFocus | Jan. 21, 2015 | 11:46AM EST
  28. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  29. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD | Jan. 5, 2015 | 18:20PM EST
  30. Isis Pharma To Develop GI Drugs With J&J

    IBD | Jan. 5, 2015 | 13:17PM EST
  31. Pfizer, Home of Lipitor and Viagra, Lifts Dividend

    IBD | Dec. 31, 2014 | 17:16PM EST
  32. Ebola Drug Work Continues

    IBD | Dec. 26, 2014 | 18:22PM EST
  33. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD | Dec. 26, 2014 | 16:09PM EST
  34. BioMarin CEO Sees Big Future For Prosensa Drug

    IBD | Dec. 23, 2014 | 16:11PM EST
  35. Weekly 3-Year Low Highlights: RDS.B, GSK, WPZ, CLR

    GuruFocus | Dec. 14, 2014 | 21:52PM EST
  36. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
  37. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus | Dec. 9, 2014 | 10:50AM EST
  38. Merck Bets $9.5 Billion On Cubist's War On Superbugs

    IBD | Dec. 8, 2014 | 18:49PM EST
  39. GlaxoSmithKline's Move A Testament That Pharma Companies Are Turning Focus Away From U.S.

    Benzinga | Dec. 1, 2014 | 11:58AM EST
  40. The Top 5 European Stocks Held During Q3

    GuruFocus | Nov. 25, 2014 | 18:19PM EST
  41. BioMarin buying Prosensa

    IBD | Nov. 24, 2014 | 18:43PM EST
  42. BioMarin Buying Prosensa, Backing Up Troubled Drug

    IBD | Nov. 24, 2014 | 10:22AM EST
  43. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  44. Jeff Auxier Buys Berkshire Hathaway in Third Quarter

    GuruFocus | Nov. 18, 2014 | 16:33PM EST
  45. Apollo may make Glaxo offer

    IBD | Nov. 13, 2014 | 18:37PM EST
  46. Irving Kahn Starts New Position In GlaxoSmithKline

    GuruFocus | Nov. 13, 2014 | 08:26AM EST
  47. Irving Kahn Buys Stake in GlaxoSmithKline During Q3 2014

    GuruFocus | Nov. 12, 2014 | 15:29PM EST
  48. Insys Q3 Beats Estimates, Helping Stock Rebound

    IBD | Nov. 11, 2014 | 11:33AM EST
  49. Kahn Brothers' Third Quarter Numbers

    GuruFocus | Nov. 7, 2014 | 17:43PM EST
  50. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 10:44AM EST
Trading Center